Novel alloxazine analogues: design, synthesis, and antitumour efficacy enhanced by kinase screening, molecular docking, and ADME studies.
Humans
Antineoplastic Agents
/ pharmacology
Structure-Activity Relationship
Drug Design
Molecular Docking Simulation
Drug Screening Assays, Antitumor
Molecular Structure
Cell Proliferation
/ drug effects
Dose-Response Relationship, Drug
Protein Kinase Inhibitors
/ pharmacology
Cell Line, Tumor
Flavins
ADME
Alloxazine
antitumor
kinase profiling
molecular docking
Journal
Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
medline:
17
9
2024
pubmed:
17
9
2024
entrez:
17
9
2024
Statut:
ppublish
Résumé
This study describes the development of novel alloxazine analogues as potent antitumor agents with enhanced selectivity for tumour cells. Twenty-nine out of 45 newly compounds were investigated
Identifiants
pubmed: 39287132
doi: 10.1080/14756366.2024.2398551
doi:
Substances chimiques
Antineoplastic Agents
0
isoalloxazine
490-59-5
Protein Kinase Inhibitors
0
Flavins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM